Research ArticleNEUROPHARMACOLOGY
S33138 [N-[4-[2-[(3aS,9bR)-8-Cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent. II. A Neurochemical, Electrophysiological and Behavioral Characterization in Vivo
Mark J. Millan, Per Svenningsson, Charles R. Ashby Jr., Michael Hill, Martin Egeland, Anne Dekeyne, Mauricette Brocco, Benjamin Di Cara, Françoise Lejeune, Nitza Thomasson, Carmen Muńoz, Elisabeth Mocaër, Alan Crossman, Laetitia Cistarelli, Sylvie Girardon, Loretta Iob, Sylvie Veiga and Alain Gobert
Journal of Pharmacology and Experimental Therapeutics February 2008, 324 (2) 600-611; DOI: https://doi.org/10.1124/jpet.107.132563
Mark J. Millan
Per Svenningsson
Charles R. Ashby Jr.
Michael Hill
Martin Egeland
Anne Dekeyne
Mauricette Brocco
Benjamin Di Cara
Françoise Lejeune
Nitza Thomasson
Carmen Muńoz
Elisabeth Mocaër
Alan Crossman
Laetitia Cistarelli
Sylvie Girardon
Loretta Iob
Sylvie Veiga
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNEUROPHARMACOLOGY
S33138 [N-[4-[2-[(3aS,9bR)-8-Cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent. II. A Neurochemical, Electrophysiological and Behavioral Characterization in Vivo
Mark J. Millan, Per Svenningsson, Charles R. Ashby, Michael Hill, Martin Egeland, Anne Dekeyne, Mauricette Brocco, Benjamin Di Cara, Françoise Lejeune, Nitza Thomasson, Carmen Muńoz, Elisabeth Mocaër, Alan Crossman, Laetitia Cistarelli, Sylvie Girardon, Loretta Iob, Sylvie Veiga and Alain Gobert
Journal of Pharmacology and Experimental Therapeutics February 1, 2008, 324 (2) 600-611; DOI: https://doi.org/10.1124/jpet.107.132563
Research ArticleNEUROPHARMACOLOGY
S33138 [N-[4-[2-[(3aS,9bR)-8-Cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent. II. A Neurochemical, Electrophysiological and Behavioral Characterization in Vivo
Mark J. Millan, Per Svenningsson, Charles R. Ashby, Michael Hill, Martin Egeland, Anne Dekeyne, Mauricette Brocco, Benjamin Di Cara, Françoise Lejeune, Nitza Thomasson, Carmen Muńoz, Elisabeth Mocaër, Alan Crossman, Laetitia Cistarelli, Sylvie Girardon, Loretta Iob, Sylvie Veiga and Alain Gobert
Journal of Pharmacology and Experimental Therapeutics February 1, 2008, 324 (2) 600-611; DOI: https://doi.org/10.1124/jpet.107.132563
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement